Zobrazeno 1 - 10
of 1 162
pro vyhledávání: '"Appleby, N."'
Publikováno v:
In Blood Reviews March 2024 64
A4 9pp +3 appendices + 5 figs + 32 plates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27ed7bc1d00ee295f05e8a0ebe5ca16d
Autor:
McDool E; From the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom., Carlton J; From the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom., Powell PA; From the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom., Coates E; From the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom., Knox L; From the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom., Mayberry E; From the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom., Appleby N; From the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom., Griffiths AW; From the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom., Hobson E; From the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom., McDermott CJ; From the Sheffield Centre for Health and Related Research (SCHARR) (E. McDool, J.C., P.A.P., E.C.), and Sheffield Institute for Translational Neuroscience (SITraN) (L.K., E. Mayberry, N.A., A.W.G., E.H., C.J.M.), University of Sheffield, Sheffield, United Kingdom.
Publikováno v:
Neurology [Neurology] 2024 Jul 23; Vol. 103 (2), pp. e209549. Date of Electronic Publication: 2024 Jun 13.
Autor:
Björkquist, M., Klem Olesen, L., la Cour, K., With, H., Handberg, C., Mioshi, E., Grant, K., Shepstone, L., Nikolajevic-Pujic, S., Knudsen, L., Malmström, N., Jakobsson Larsson, B., Nilsson, S., Öhlén, J., Nygren, I., Andersen, P., Ozanne, A., Appleby, N., Mayberry, E., McDermott, C.
Publikováno v:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration; 2023 Suppl1, Vol. 24, p245-257, 13p
Autor:
Appleby, N.1 applebyn@gmail.com, Groarke, E.2, Crowley, M.1, Wahab, F. A.2, McCann, A. M.1, Egan, L.1, Gough, D.1, McMahon, G.3, O'Donghaile, D.1, O'Keeffe, D.2, O'Connell, N.1
Publikováno v:
Transfusion Medicine. Feb2017, Vol. 27 Issue 1, p66-71. 6p.
Autor:
Robbe P; Department of Oncology, University of Oxford, Oxford, UK.; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., Ridout KE; Department of Oncology, University of Oxford, Oxford, UK., Vavoulis DV; Department of Oncology, University of Oxford, Oxford, UK., Dréau H; Department of Oncology, University of Oxford, Oxford, UK., Kinnersley B; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK., Denny N; Department of Medicine, Medical Research Council Molecular Haematology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Chubb D; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK., Appleby N; Department of Oncology, University of Oxford, Oxford, UK., Cutts A; Department of Oncology, University of Oxford, Oxford, UK., Cornish AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK., Lopez-Pascua L; UK Health Security Agency, London, UK., Clifford R; Department of Haematology, University Hospital Limerick, Limerick, Ireland.; Limerick Digital Cancer Research Centre, School of Medicine,University of Limerick, Limerick, Ireland., Burns A; Department of Oncology, University of Oxford, Oxford, UK., Stamatopoulos B; Laboratory of Clinical Cell Therapy, Jules Bordet Institute, ULB Cancer Research Center (U-CRC)- Université Libre de Bruxelles (ULB), Brussels, Belgium., Cabes M; Oxford Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK., Alsolami R; Department of Medical Laboratory Technology, King Abdulaziz University, Jeddah, Saudi Arabia., Antoniou P; Illumina Cambridge Ltd., Cambridge, UK., Oates M; University of Liverpool, Liverpool, UK., Cavalieri D; Department of Haematology, CHU de Clermont-Ferrand, Clermont-Ferrand, France., Gibson J; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Prabhu AV; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., Schwessinger R; Department of Medicine, Medical Research Council Molecular Haematology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Jennings D; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan., James T; Illumina Cambridge Ltd., Cambridge, UK., Maheswari U; Illumina Cambridge Ltd., Cambridge, UK., Duran-Ferrer M; Biomedical Epigenomics Group, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain., Carninci P; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.; Human Technopole, Milan, Italy., Knight SJL; Oxford University Clinical Academic Graduate School, University of Oxford Medical Sciences Division, University of Oxford, John Radcliffe Hospital, Oxford, UK., Månsson R; Center for Hematology and Regenerative Medicine Huddinge, Karolinska Institute, Stockholm, Sweden., Hughes J; Department of Medicine, Medical Research Council Molecular Haematology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Davies J; Department of Medicine, Medical Research Council Molecular Haematology Unit, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Ross M; Illumina Cambridge Ltd., Cambridge, UK., Bentley D; Illumina Cambridge Ltd., Cambridge, UK., Strefford JC; Cancer Genomics, Cancer Sciences, Faculty of Medicine, Group University of Southampton, Southampton, UK., Devereux S; King's College Hospital, NHS Foundation Trust, London, UK.; Kings College London, London, UK., Pettitt AR; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.; Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK., Hillmen P; St James's University Hospital, Leeds, UK., Caulfield MJ; Genomics England, London, UK.; William Harvey Research Institute, Queen Mary University of London, London, UK., Houlston RS; Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, UK., Martín-Subero JI; Human Technopole, Milan, Italy.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Schuh A; Department of Oncology, University of Oxford, Oxford, UK. anna.schuh@oncology.ox.ac.uk.
Publikováno v:
Nature genetics [Nat Genet] 2022 Nov; Vol. 54 (11), pp. 1675-1689. Date of Electronic Publication: 2022 Nov 04.
Cellular Therapy in High-Risk Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter Syndrome.
Autor:
Barbanti MC; Department of Clinical Haematology, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.; Clinical Trials Unit, Department of Oncology, Churchill Hospital, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, United Kingdom., Appleby N; Department of Clinical Haematology, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.; Clinical Trials Unit, Department of Oncology, Churchill Hospital, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, United Kingdom., Kesavan M; Department of Clinical Haematology, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.; Clinical Trials Unit, Department of Oncology, Churchill Hospital, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, United Kingdom., Eyre TA; Department of Clinical Haematology, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.; Clinical Trials Unit, Department of Oncology, Churchill Hospital, Oxford University Hospitals NHS Trust, University of Oxford, Oxford, United Kingdom.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Apr 28; Vol. 12, pp. 888109. Date of Electronic Publication: 2022 Apr 28 (Print Publication: 2022).
Publikováno v:
In Social Science & Medicine 2002 54(8):1225-1241
Autor:
Klintman J; Molecular Diagnostic Centre, Department of Oncology, University of Oxford, Oxford, United Kingdom.; Department of Oncology, University of Oxford, Oxford, United Kingdom.; Department of Translational Medicine, Skåne University Hospital, Lund University, Lund, Sweden., Appleby N; Molecular Diagnostic Centre, Department of Oncology, University of Oxford, Oxford, United Kingdom.; Department of Oncology, University of Oxford, Oxford, United Kingdom.; Department of Hematology, Oxford University Hospitals National Health Service (NHS) Trust, Oxford, United Kingdom., Stamatopoulos B; Molecular Diagnostic Centre, Department of Oncology, University of Oxford, Oxford, United Kingdom.; Laboratory of Clinical Cell Therapy, Jules Bordet Institute, Université Libre de Bruxelles (ULB), Brussels, Belgium., Ridout K; Molecular Diagnostic Centre, Department of Oncology, University of Oxford, Oxford, United Kingdom.; Department of Oncology, University of Oxford, Oxford, United Kingdom., Eyre TA; Department of Hematology, Oxford University Hospitals National Health Service (NHS) Trust, Oxford, United Kingdom., Robbe P; Molecular Diagnostic Centre, Department of Oncology, University of Oxford, Oxford, United Kingdom.; Department of Oncology, University of Oxford, Oxford, United Kingdom., Pascua LL; Molecular Diagnostic Centre, Department of Oncology, University of Oxford, Oxford, United Kingdom.; Department of Oncology, University of Oxford, Oxford, United Kingdom., Knight SJL; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom., Dreau H; Molecular Diagnostic Centre, Department of Oncology, University of Oxford, Oxford, United Kingdom.; Department of Oncology, University of Oxford, Oxford, United Kingdom., Cabes M; Department of Hematology, Oxford University Hospitals National Health Service (NHS) Trust, Oxford, United Kingdom., Popitsch N; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.; The Children's Cancer Research Institute (CCRI), Vienna, Austria., Ehinger M; Pathology, Department of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden., Martín-Subero JI; Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Campo E; Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain., Månsson R; Center for Hematology and Regenerative Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.; Hematology Center, Karolinska University Hospital, Stockholm, Sweden; and., Rossi D; Institute of Oncology Research (IOR), Bellinzona, Switzerland., Taylor JC; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom., Vavoulis DV; Molecular Diagnostic Centre, Department of Oncology, University of Oxford, Oxford, United Kingdom.; Department of Oncology, University of Oxford, Oxford, United Kingdom.; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.; Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom., Schuh A; Molecular Diagnostic Centre, Department of Oncology, University of Oxford, Oxford, United Kingdom.; Department of Oncology, University of Oxford, Oxford, United Kingdom.; Department of Hematology, Oxford University Hospitals National Health Service (NHS) Trust, Oxford, United Kingdom.; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
Publikováno v:
Blood [Blood] 2021 May 20; Vol. 137 (20), pp. 2800-2816.
Autor:
Abdelfattah, Fatima1 (AUTHOR) fatima.abdelfattah@med.ovgu.de, Schulz, Herbert1,2 (AUTHOR) herbert.schulz@med.ovgu.de, Wehland, Markus1,2 (AUTHOR) markus.wehland@med.ovgu.de, Corydon, Thomas J.3,4 (AUTHOR) corydon@biomed.au.dk, Sahana, Jayashree3 (AUTHOR) jaysaha@biomed.au.dk, Kraus, Armin1,2 (AUTHOR) armin.kraus@med.ovgu.de, Krüger, Marcus1,2 (AUTHOR) marcus.krueger@med.ovgu.de, González-Torres, Luis Fernando1 (AUTHOR) luis.gonzaleztorres@med.ovgu.de, Cortés-Sánchez, José Luis1 (AUTHOR) jose.cortes@ovgu.de, Wise, Petra M.1,5 (AUTHOR) petra.wise@med.ovgu.de, Mushunuri, Ashwini1 (AUTHOR) ashwini.mushunuri@med.ovgu.de, Hemmersbach, Ruth6 (AUTHOR) ruth.hemmersbach@dlr.de, Liemersdorf, Christian6 (AUTHOR) christian.liemersdorf@dlr.de, Infanger, Manfred1,2 (AUTHOR) manfred.infanger@med.ovgu.de, Grimm, Daniela1,2,3 (AUTHOR) dgg@biomed.au.dk
Publikováno v:
International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 18, p10014. 58p.